Spinal anesthesia with tetracaine in 0.75% Glucose: Influence of the vertebral interspace used for injection

Regional Anesthesia and Pain Medicine

Volumn 23, Issue 2, 1998, Pages 170-175

  Sakura, Shinichi ^a   Sumi, Mariko ^a   Morimoto, Noriko ^a   Yamamori, Yuji ^a   Saito, Yoji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Anesthesia; Baricity; Phenylephrine; Spinal; Tetracaine

Indexed keywords

PHENYLEPHRINE; TETRACAINE;

ADULT; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOME; FEMALE; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYPERBARISM; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; PRIORITY JOURNAL; SCORING SYSTEM; SPINAL ANESTHESIA; SURGICAL ANATOMY;

EID: 0031839768     PISSN: 0146521X     EISSN: None     Source Type: Journal    
DOI: 10.1136/rapm-00115550-199823020-00010     Document Type: Article

References (19)

1. Sanderson P, Read J, Littlewood DG, McKeown D, Wildsmith JAW. Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread. Br J Anaesth 1994: 73: 744-746.
2. Sumi M, Sakura S, Sakaguchi Y, Saito Y, Kosaka Y. Comparison of glucose 7.5% and 0.75% with or without phenylephrine for tetracaine spinal anaesthesia. Can J Anaesth 1996: 43: 1138-1143.
3. Liu S, Pollock JE, Mulroy MF, Allen HW, Neal JM, Carpenter RL. Comparison of 5% with dextrose, 1.5% with dextrose, and 1.5% dextrose-free lidocaine solutions for spinal anesthesia in human volunteers. Anesth Analg 1995: 81: 697-702.
4. Mitchell RWD, Bowler GMR, Scott DB, Edstrom HH. Effects of posture and baricity on spinal anaesthesia with 0.5% bupivacaine 5 ml: A double-blind study. Br J Anaesth 1988: 61: 139-143.
5. Van Gessel EF, Forster A, Schweizer A, Gamulin Z. Comparison of hypobaric, hyperbaric, and isobaric solutions of bupivacaine during continuous spinal anesthesia. Anesth Analg 1991: 72: 779-784.
6. Bannister J, McClure JH, Wildsmith JAW. Effect of glucose concentration on the intrathecal spread of 0.5% bupivacaine. Br J Anaesth 1990: 64: 232-234.
7. Chambers WA, Edstrom HH, Scott DB. Effect of baricity on spinal anaesthesia with bupivacaine. Br J Anaesth 1981: 53: 279-282.
8. Moller IW, Fernandes A, Edstrom HH. Subarachnoid anaesthesia with 0.5% bupivacaine: Effects of density. Br J Anaesth 1984: 56: 1191-1195.
9. Lee A, Ray D, Littlewood DG, Wildsmith JAW. Effect of dextrose concentration on the intrathecal spread of amethocaine. Br J Anaesth 1988: 61: 135-138.
10. Brown DT, Wildsmith JAW, Covino BG, Scott DB. Effect of baricity on spinal anaesthesia with amethocaine. Br J Anaesth 1980: 52: 589-596.
11. Tuominen M, Taivainen T, Rosenberg PH. Spread of spinal anaesthesia with plain 0.5% bupivacaine: Influence of the vertebral interspace used for injection. Br J Anaesth 1989: 62: 358-361.
12. Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg 1985: 64: 715-730.
13. Hirabayashi Y, Saitoh K, Fukuda H, Shimizu R. Atropine has little significance as a premedicant for spinal anesthesia. Masui 1994: 43: 306-310.
14. Moore DC. Guest discussion. Anesth Analg 1970: 49: 916-917.
15. levins FA. Accuracy of placement of extradural needles in the L3-4 interspace: Comparison of two methods of identifying L4. Br J Anaesth 1991: 66: 381-382.
16. Pitkanen MT. Body mass and spread of spinal anesthesia with bupivacaine. Anesth Analg 1987: 66: 127-131.
17. Carpenter R, Hogan Q, Liu S, Crane B. Spinal CSF volume is the primary determinant of sensory block height and duration of spinal anesthesia. Anesthesiology 1996: 85: A736.
18. Hogan QH, Prost R, Kulier A, Taylor ML, Liu S, Mark L. Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology 1996: 84: 1341-1349.
19. Sakura S, Sumi M, Sakaguchi Y, Saito Y, Kosaka Y, Drasner K. The addition of phenylephrine contributes to the development of transient neurologic symptoms after spinal anesthesia with 0.5% tetracaine. Anesthesiology 1997: 87: 771-778.